NORCROSS, Ga., March 27 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Phil Moise has agreed to join Immucor as Vice President, General Counsel and Secretary effective April 1, 2007. Mr. Moise was most recently a partner and Co-Chair of Life Sciences at Sutherland Asbill & Brennan LLP in Atlanta. Mr. Moise has represented the company for over 20 years, acting as its outside general counsel. During a 30-years career in private practice he has also represented over 35 other public and private companies in the life sciences and medical products industries. Mr. Moise graduated with honors from The Citadel and Duke University School of Law. He will serve as Immucor’s first inside general counsel.
Dr. Gioacchino De Chirico, President and Chief Executive Officer stated, “We are extremely pleased to have an individual with the expertise and background that Phil Moise brings to the company. He has led almost all of the company’s legal work, including two public offerings and all of the company’s domestic and international acquisitions. As Immucor has grown and our business has become increasingly complex, we have needed someone like Phil on a fulltime basis.”
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of our market segments.
For more information on Immucor, please visit our website at www.immucor.com.
Immucor, Inc.
CONTACT: Patrick Waddy of Immucor, Inc., +1-770-441-2051
Web site: http://www.immucor.com/
